This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp™ Featured In Dentistry Today

United Health Products, Inc. (OTCQB: UEEC.PK) and its wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp™, has been featured in the January 2013 edition of Dentistry Today. The article states that while there are other "hemostatic agents available to the dental practitioner, most of them are difficult to place, difficult to keep in position, and difficult to remove without disturbing the clotted surface, thereby reinitiating the bleeding. This specifically formulated gauze produces hemostasis almost instantly when positioned on a cut or wound. It contains no potentially harmful chemicals such as thrombin, collagen, or animal byproducts, is hypoallergenic, and works more quickly than other hemostatic agents. Once it has completed its task, it is readily dissolved by saline solution or water for easy removal that neither disturbs the clotted surface nor encourages re-bleeding." Dentistry Today is a top dental industry report offering comprehensive coverage of the latest news and developing technologies from within the dental industry through both print and online offerings.

Dr. Phillip Forman, CEO of United Health Products Inc., stated that "the coverage of our product by Dentistry Today continues to validate the HemoStyp™ gauze and our marketing efforts for its use within the dental industry." Dr. Forman went on to say that "In addition to Dentistry Today, our product was also highlighted several times in the last few months in the Clinicians Report ® , another well known dental industry publication." In the December issue of the Clinicians Report ®, HemoStyp™ was listed among the "Best Products Evaluated During 2012" with 83% of the evaluators stating that they would recommend the product. The company has received an initial order from one of the dental industry’s largest dental products distributors. Dr. Forman further states that he hopes that the continued coverage and testimony by multiple industry publications generates the same kind of interest in the product. The January 2013 issue of Dentistry Today can be purchased or viewed at the following link for a nominal fee – http://www.dentistrytoday.com/articles/articles/185-table-of-contents/8497-january-2013

About United Health Products, Inc.

United Health Products, Inc. (UEEC) develops, manufactures and markets products and technologies in the healthcare sector. UEEC's operating subsidiary Epic Wound Care, Inc. produces hemostatic gauze, derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying emerging healthcare products and technologies for strategic partnership or acquisition.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs